BamSEC and AlphaSense Join Forces
Learn More

Lomond Therapeutics Holdings, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.21
from 8-K 10 pages Lock-Up Agreement
12/34/56
EX-10.20
from 8-K 2 pages Assignment and Consent Agreement
12/34/56
EX-10.19
from 8-K 2 pages Assignment and Consent Agreement
12/34/56
EX-10.18
from 8-K 6 pages Promissory Note
12/34/56
EX-10.17
from 8-K 7 pages Promissory Note
12/34/56
EX-10.16
from 8-K 1 page Lomond Therapeutics, Inc. Promissory Note
12/34/56
EX-10.15
from 8-K 1 page Lomond Therapeutics, Inc. Promissory Note
12/34/56
EX-10.14
from 8-K 3 pages Lomond Therapeutics, Inc. Promissory Note
12/34/56
EX-10.13
from 8-K 16 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Are the Type of Information That the Registrant Treats as Private or Confidential and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made. License Agreement
12/34/56
EX-10.12
from 8-K 4 pages Lomond Therapeutics, Inc. Promissory Note
12/34/56
EX-10.11
from 8-K 15 pages License Agreement
12/34/56
EX-10.10
from 8-K 10 pages Indemnification Agreement
12/34/56
EX-10.9
from 8-K 28 pages Lomond Therapeutics Holdings, Inc. 2024 Equity Incentive Plan (As Adopted on November 1, 2024) (Approved by the Stockholders on November 1, 2024) Lomond Therapeutics Holdings, Inc. 2024 Equity Incentive Plan
12/34/56
EX-10.8
from 8-K 70 pages Lomond Therapeutics, Inc. 2024 Stock Plan Adopted on September 19, 2024
12/34/56
EX-10.7
from 8-K 44 pages I Eilean Therapeutics LLC 2022 Equity Incentive Plan
12/34/56
EX-10.6
from 8-K 35 pages Form of Registration Rights Agreement
12/34/56
EX-10.5
from 8-K 52 pages Subscription Agreement
12/34/56
EX-10.4
from 8-K 8 pages Indemnity Agreement
12/34/56
EX-10.3
from 8-K 5 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Are the Type of Information That the Registrant Treats as Private or Confidential and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made. Lomond Therapeutics, Inc. Consulting Agreement
12/34/56
EX-10.2
from 8-K 4 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Are the Type of Information That the Registrant Treats as Private or Confidential and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made. Lomond Therapeutics, Inc. Consulting Agreement
12/34/56